Skip to Main Content

Paper Details

Safety and Outcomes of Intravenous Thrombolytic Therapy in Ischemic Stroke Patients with COVID-19: CASCADE Initiative.
J Stroke Cerebrovasc Dis
12
2021
COVID-19, High-sensitivity C reactive protein, IV-tPA, Ischemic Stroke, Patients, acute ischemic stroke, hemorrhagic transformation, hyper acute stroke, patients, stroke, tPA, tissue plasminogen activator
Author NameAffiliation
Georgios TsivgoulisSecond Department of Neurology National & Kapodistrian University of Athens,Professor of Neurology
Yama Akbariand Beckman Laser Institute & Medical Clinic, University of California irvine
David S Liebeskinduniversity of california los angeles Stroke Center
David S Liebeskinduniversity of california los angeles Stroke Center
  • 1 - 4

Datasets

Release 1.2